POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors
Conditions: Melanoma; Non-Small Cell Lung Cancer Interventions: Other: Standard-of-care procedures; Other: Study procedures Sponsor: Prof.dr. E.G.E. de Vries Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Melanoma | Non-Small Cell Lung Cancer | Research | Skin Cancer | Study